These grants are awarded for novel research projects that address finding cures for epilepsy and address the goal of “no seizures, no side-effects.”
These grants are awarded for novel research projects that address finding cures for epilepsy and address the goal of “no seizures, no side-effects.”
Preventive treatment with vigabatrin effectively altered the natural history of seizures among infants with tuberous sclerosis complex, decreasing the risk for and severity of epilepsy, according to results published in Annals of Neurology.
"This new indication gives people suffering from primary generalized tonic-clonic seizures (PGTCS) a chance at freedom from these seizures, ” said David Vossler, MD, FAAN FACNS FAES, Department of Neurology, University of Washington, Seattle, USA.
Focal epilepsy in adults is associated with progressive atrophy of the cortex at a rate more than double that of normal ageing. We aimed to determine whether successful epilepsy surgery interrupts progressive cortical thinning...Read More
Late-onset epilepsy is linked to a substantial increased risk of subsequent dementia. Results of a retrospective analysis show that patients who develop epilepsy at age 67 or older have a threefold increased risk of subsequent dementia versus their counterparts without epilepsy...Read More
Precision medicine can be distilled into a concept of accounting for an individual’s unique collection of clinical, physiologic, genetic, and sociodemographic characteristics to provide patient?level predictions of disease course and response to therapy...Read More
Epilepsy with myoclonic-atonic seizures (EMAS) is a rare childhood onset epileptic encephalopathy. There is no clear consensus for recommended treatments, and pharmacoresistance is common...Read More
Dravet syndrome now has its own global health statistics codes — known as “ICD-10” codes — that potentially could result in improved patient outcomes and enhanced clinical and scientific knowledge of the genetic disorder...Read More
